Eclipsebio
PrivateLast Round
Grant
Jan 13, 2025
Total Funding Raised
$19.32M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Eclipsebio is a biotechnology company that develops first-in-class technologies, analyses, and platforms for the development of RNA-based and RNA-targeting therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eclipsebio Comparables
Compare Eclipsebio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alida Biosciences | 84% | |
| Atomic AI | 83% | |
| Envisagenics | 81% |
Eclipsebio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 13, 2025 | ||||
| Grant | Jul 1, 2024 | ||||
| Series A | Mar 15, 2022 | ||||
| Seed | Jun 5, 2020 | ||||
| Grant | Sep 17, 2019 | ||||
Grant | Sep 20, 2017 |
Eclipsebio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Phoenix Venture Partners | Series A |
| NIH RADx | Grant |
| Alexandria Venture Investments | Series A |
| iGlobe Partners | Series A |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 42% MoM, reaching 10.3K.
- Apr 21, 2026
Launched eCOMPASS platform for AI-driven RNA therapeutic development.
Recent news
Latest coverage and updates
- launchesSep 10, 2026
Eclipse Bioinnovations launched eSTRAND RNA QC on Sep 10th '26.
Eclipsebio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Eclipsebio's valuation, stock price, and market status.
Is Eclipsebio a public or private company?
Eclipsebio is a private company.
What is the current stock price of Eclipsebio?
Eclipsebio is a private company with no public stock price. No recent secondary market data is available.
How much is Eclipsebio worth (valuation)?
Valuation information for Eclipsebio is not publicly available.
Can I buy Eclipsebio stock?
Eclipsebio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Eclipsebio's last funding round?
Eclipsebio's most recent funding round was Grant on July 1, 2024.
Who are the main investors in Eclipsebio?
Key investors in Eclipsebio include Alexandria Venture Investments.
Will Eclipsebio IPO soon?
No public IPO plans have been announced for Eclipsebio.
How can I track Eclipsebio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eclipsebio's secondary market activity and sign up for updates.